Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Dividends payables (2016)

Altimmune (ALT) has disclosed Dividends payables for 1 consecutive years, with $197.1 million as the latest value for Q4 2016.

  • Quarterly Dividends payables changed N/A to $197.1 million in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $197.1 million through Dec 2016, changed N/A year-over-year, with the annual reading at $197.1 million for FY2016, N/A changed from the prior year.
  • Dividends payables for Q4 2016 was $197.1 million at Altimmune.
  • The five-year high for Dividends payables was $197.1 million in Q4 2016, with the low at $197.1 million in Q4 2016.